Thallium(III) p-tosylate mediated oxidative 2,3-aryl rearrangement: A new useful route to ipriflavone and its analogs

Synthetic Communications

Volumn 38, Issue 22, 2008, Pages 3875-3883

  Muthukrishnan, M ^a,b   Singh, Om V ^a  

^a JAWAHARLAL NEHRU TROPICAL BOTANIC GARDEN AND RESEARCH INSTITUTE   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

Flavanones; Ipriflavone; Isoflavones; Oxidative rearrangement; Thallium(III) p tosylate

Indexed keywords

7 ISOPROPYLOXY 3',4' METHYLENEDIOXYFLAVANONE; 7 ISOPROPYLOXY 3',4' METHYLENEDIOXYISOFLAVONE; 7 ISOPROPYLOXY 4' METHOXYFLAVANONE; 7 ISOPROPYLOXY 4' METHOXYISOFLAVONE; 7 ISOPROPYLOXYFLAVANONE; 7 ISOPROPYLOXYISOFLAVONE; FLAVANONE; IPRIFLAVONE; ISOFLAVONE; THALLIUM; TOLUENESULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; METHODOLOGY; NONHUMAN; OXIDATION; REACTION ANALYSIS; SYNTHESIS;

EID: 54349107475     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397910802238734     Document Type: Article

References (26)

1. (a) Ingham, J. L. In Phytoalexins; I. A. Baily, J. W. Mansfield (Eds.); Blackie: Glasgow and London, 1982; p. 21;
2. (b) Ingham, J. L. Naturally occurring isoflavonoids (1855-1981). Prog. Chem. Org. Nat. Prod. 1983, 43(1), 1-266;
3. (c) Dewick, P. M. In The Flavonoids: Advances in research since 1986" J. B. Harborne, (Ed.); Chapman & Hall: London, 1993; p. 149;
4. (d) Dixon, R. A. In Comprehensive Natural Products Chemistry; D. H. R. Barton, R. Nakanishi (Eds.); Elsevier: Oxford, 1999; vol. 1, p. 773.
5. Miksicek, R. J. Estrogenic flavonoids: Structural requirements for biological activity. Proc. Soc. Exp. Biol. Med. 1995, 208(1), 44-50.
6. Yanagihara, K.; Ito, A.; Toge, T.; Numoto, M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 1993, 53(23), 5815-5821.
7. Bandyukova, V. A.; Cherevatye, V. S.; Ozimina, I. I.; Andreeva, O. A.; Lebedava, A. L.; Davydov, V. S.; Vashchenko, T. N.; Postnikova, N. V. Antibacterial activity of flavonoids of some flowering plant species. Rastit Resur. 1987, 23, 607-612.
8. El-Gammal, A. A.; Mansour, R. M. Antimicrobial activities of some flavonoid compounds. Zentralbl Mikrobiol. 1986, 141(7), 561-565.
9. Takai, M.; Yamaguchi, H.; Saitoh, T.; Shibata, S. Chemical studies on the oriental plant drugs XXXV: The chemical constituents of the Heartwood of Maackia amurensis. Var. Buergeri. Chem. Pharm. Bull. 1972, 20, 2488-2490.
10. Akiyama, T.; Ishida, J.; Nakagawa, S.; Ogawara, H.; Watanabe, S.; Itoh, N.; Shihuya, M.; Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 1987, 262(12), 5592-5595.
11. Nogradi, M. The ipriflavone story (1969-1993). Khem. Kozl. 1993, 77(1), 55-58.
12. (a) Kleemann, A.; Engel, J. Pharmaceutical Substances: Synthesis, Patents, Applications, 4th ed.; Georg Thieme Verlag, Stuttgart and New York, 2001; 1094;
13. (b) Elks, J.; Ganellin, C. R. Dictionary of Drugs; Chapmann and Hall: London, 1991; p. 651;
14. (c) Vincent, A.; Fitzpatrick, L. A. Soy isoflavones: Are they useful in menopause? Mayo Clin. Proc. 2000, 75, 1174-1184, and references cited therein.
15. (a) Kunikata, K.; Fukunaga, K. Method for the preparation and purification of 7-isopropoxyisoflavone. JP Patent 09268187, Jpn. Kokai Tokkyo Koho. 1997;
16. (b) Imamiya, K.; Kawamoto, H. Preparation of 7-isopropoxyisoflavone from 7-hydroxyisoflavone and isopropyl sulfonates. JP 11012265, Jpn. Kokai Tokkyo Koho. 1999.
17. (a) Feuer, L.; Nogradi, M.; Gottsegen, A.; Vermes, B.; Streliszky, J.; Wolfner, A.; Farkas, L.; Antus, S.; Kovacs, M. Isoflavone derivatives as feed additives. Ger. Offen. 2,125,245, 1972;
18. (b) Kallay, T.; Lanyi, G.; Ledniczky, L.; Imrei, L.; Hoffmann, G.; Sziladi, M.; Somfai, E.; Montay, T. An improved process for the preparation of substituted isoflavone derivatives. PCT Int. Appl. WO 9115483, 1991;
19. (c) Nogradi, M.; Gottsegen, A.; Antus, S.; Streliszky, J.; Vermes, B.; Wolfner, A.; Major, A.; Szuels, J.; Bendeffy, J.; Marmarosi, T. Isoflavone derivatives. PCT Int. Appl. WO 9503,293, 1995;
20. (d) Kunikata, K.; Fukunaga, K. Preparation and purification of 7-hydroxy isoflavone as pharmaceutical intermediate. JP 09157268, Jpn. Kokai Tokkyo Koho. 1997.
21. Orjales-Venero, A.; Canal-Mori, G.; Mosquera-Pestana, R. Process for the preparation of 7-isopropoxyisoflavone. ES 2072802, Span 1995.
22. Singh, O. V.; Garg, C. P.; Kapoor, R. P. Oxidative 1,2-aryl rearrangement in flavanones using thallium(III) p-tolyl sulphonate (TTS): A new useful route to isoflavones. Tetrahedron Lett. 1990, 31(19), 2747-2750.
23. Singh, O. V.; Kapil, R. S. A general method for the synthesis of isoflavones by oxidative rearrangement of flavanones using thallium(III) perchlorate. Indian J. Chem. 1993, 32B(9), 911-915.
24. Singh, O. V.; Muthukrishnan, M.; Sundaravadivelu, M. Synthesis of isoflavones containing naturally occurring substitution pattern by oxidative rearrangement of respective flavanones using thallium(III) p-tosylate. Indian J. Chem. 2005, 44B(12), 2575-2581.
25. Kazuhiko, I.; Hitoshi, T.; Kazuo, I.; Toshihiro, T.; Mizuo. Synthesis of Helilandin B, pashanone, and their isomers. J. Nat. Prod. 1988, 51(5), 906-914.
26. Singh, O. V.; Kapil, R. S. A new route to 2-aryl-4-quinolones via thallium(III) p-tolylsulfonate-mediated oxidation of 2-aryl-1,2,3,4- tetrahydro-4-quinolones. Synth. Commun. 1993, 23(3), 277-283.